Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

VIVS stock hub

VivoSim Labs, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VIVSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

VIVS

In the news

Latest news · VIVS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-51.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-206.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VIVS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

195

Groups with data

Currency

USD

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001497253
Company name	VivoSim Labs, Inc.
Country	United States
Country code	US
Employees	14
Employees Change	0%
Employees Change Percent	0
Enterprise value	$547,381
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US68620A3023
Last refreshed	2026-05-10
Market cap	$4M
Market cap category	Nano-Cap
Price	$1.39
Price currency	USD
Rev Per Employee	10,142.86x
Sector	Healthcare
Sic	2836
Symbol	VIVS
Website	https://vivosim.ai

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-30.5%
EV Sales Forward	9.94x
EV/Sales	3.85x
FCF yield	-264.06%
P/B ratio	0.82x
P/S ratio	28.33x
PS Forward	73.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-3.8M
Net Income	$-1.2M
Net Income Growth Quarters	8%
Net Income Growth Years	2%
Pretax Margin	-862.68%
Profit Per Employee	$-87,643
ROA	-132.5
Roa5y	-46.48
ROCE	-255.4
ROE	-51.07
Roe5y	-70.04
ROIC	-206.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-45.75%
Cagr1y	-28.73%
Cagr3y	-60.63%
Cagr5y	-56.51%
EPS Growth Quarters	8
EPS Growth Years	2
Revenue Growth	16.39x
Revenue Growth Q	8.33x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	-56.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.03
Assets	$7M
Cash	$4.3M
Current Assets	$6M
Current Liabilities	$2.5M
Debt	$812,000
Debt Equity	$0.18
Equity	$4.4M
Interest Coverage	-881.1
Liabilities	$2.5M
Long Term Assets	$919,000
Long Term Liabilities	$44,000
Net Cash	$3.5M
Net Cash By Market Cap	$86.4
Net Debt Equity	$-0.78
Tangible Book Value	$4.4M
Tangible Book Value Per Share	$1.7
WACC	10.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.44
Net Working Capital	$46,000
Quick ratio	1.75
Working Capital	$3.6M
Working Capital Turnover	$0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-84.51%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.78%
1Y total return	-28.72%
200-day SMA	2.17
3Y total return	-93.9%
50-day SMA	1.64
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.44%
All Time High	3,276
All Time High Change	-99.96%
All Time High Date	2013-11-18
All Time Low	1.25
All Time Low Change	11.2%
All Time Low Date	2026-04-01
ATR	0.12
Beta	1.41
Beta1y	2.23
Beta2y	1.12
Ch YTD	-23.2
High	1.43
High52	5.3
High52 Date	2025-09-15
High52ch	-73.77%
Low	1.38
Low52	1.25
Low52 Date	2026-04-01
Low52ch	11.2%
Ma50ch	-14.98%
Premarket Change Percent	-2.84
Premarket Price	$1.37
Premarket Volume	885
Price vs 200-day SMA	-35.97%
RSI	37.48
RSI Monthly	32.69
RSI Weekly	39.08
Sharpe ratio	0.23x
Sortino ratio	0.49
Total Return	-84.51%
Tr YTD	-23.2
Tr1m	-14.2%
Tr1w	-3.47%
Tr3m	-39.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-11.5M
Operating margin	-8,066.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,581,213%
Float Percent	89.18%
Net Borrowing	-246,000
Shares Insiders	10.82%
Shares Institutions	3.73%
Shares Out	2,894,519
Shares Qo Q	0.12%
Shares Yo Y	84.51%
Short Float	1.08%
Short Ratio	0.27
Short Shares	0.97

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-10.9M
Average Volume	47,109.35x
Bv Per Share	1.7
Ch10y	-99.78
Ch1m	-14.2
Ch1w	-3.47
Ch1y	-28.72
Ch3m	-39.04
Ch3y	-93.9
Ch5y	-98.44
Ch6m	-36.24
Change	-1.42%
Change From Open	-0.71
Close	1.41
Days Gap	-0.71
Depreciation Amortization	233,000
Dollar Volume	26,264.1
Earnings Date	2026-06-04
Earnings Time	amc
EBIT	$-11.5M
EBITDA	$-11.2M
EPS	$-0.53
F Score	3
FCF	$-10.6M
FCF EV Yield	-1,940.88x
FCF Per Share	$-3.67
Financing CF	4,750,000
Fiscal Year End	March
Founded	2,007
Income Tax	$2,000
Investing CF	9,001,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Last Split Date	2025-03-21
Last Split Type	Reverse
Last10k Filing Date	2025-06-05
Ma150	2.04
Ma150ch	-31.73%
Ma20	1.47
Ma20ch	-5.25%
Net CF	3,127,000
Next Earnings Date	2026-06-04
Open	1.4
Optionable	No
Position In Range	20.83
Post Close	1.39
Postmarket Change Percent	2.16
Postmarket Price	$1.42
Ppne	773,000
Pre Close	1.41
Price Date	2026-05-08
Ptbv Ratio	0.91
Relative Volume	0.4x
Revenue	142,000x
SBC By Revenue	216.9x
Share Based Comp	308,000
Tax By Revenue	1.41x
Tr6m	-36.24%
Us State	California
Volume	18,895
Z Score	-73.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does VIVS pay a dividend?

Capital-return profile for this ticker.

Performance

VIVS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VIVS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.7%

Float: +89.2% of shares outstanding

Insider ownership

+10.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

VIVS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.5

Neutral momentum band

Price vs 200-day MA

-36.0%

50/200-day relationship not available

Beta (5Y)

1.41

More volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VIVS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current VIVS stock rating?

VivoSim Labs, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full VIVS analysis?

The full report lives at /stocks/VIVS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for VIVS?

The latest report frames VIVS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the VIVS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.